Recruiting

Factor Xa Inhibition

Sponsor:

Vanderbilt University Medical Center

Code:

NCT05009862

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Rivaroxaban 2.5 Mg Oral Tablet

Placebo

Aspirin 81Mg Ec Tab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information